Robert F Grimble1. 1. Institute of Human Nutrition, School of Medicine, University of Southampton, Southampton SO16 7PX, UK. rfgl@soton.ac.uk
Abstract
PURPOSE OF REVIEW: During ageing there may be the onset of a chronic inflammatory state. This review examines the underlying causes of this phenomenon and the role that genotype plays in its intensity. RECENT FINDINGS: There are predisposing factors for the chronic inflammation that occurs during ageing. These include increased oxidative stress, a decrease in ovarian function, a decrease in stress-induced glucocorticoid sensitivity of pro-inflammatory cytokine production in men, and an increased incidence of asymptomatic bacteriuria. Obesity induces chronic inflammation. Inflammation is a key factor in the progressive loss of lean tissue and impaired immune function observed in ageing. Polymorphisms in the promoter regions of pro- and anti-inflammatory cytokine genes influence the level of cytokine production and the ageing process. Thus, a genotype for high pro-inflammatory cytokine production results in high cytokine production and may accelerate the rate of tissue loss. Conversely, polymorphisms in the genes for anti-inflammatory cytokines may result in a slowing of tissue loss. In the healthy aged male population, the former polymorphisms are under-represented and the latter over-represented, indicating a genetically determined survival advantage in maintaining inflammation at a low level. Nutrients with anti-inflammatory properties, such as vitamin E and n-3 polyunsaturated fatty acid, may reduce the level of chronic inflammation and thereby ameliorate tissue and functional loss during ageing. New evidence suggests that, for the latter nutrient, gene-nutrient interactions occur that alter the effectiveness of dietary therapy. SUMMARY: Ageing is associated with increased levels of chronic inflammation. This plays a major role in the decline in immune function and lean body mass. Anti-inflammatory nutrient therapy may slow the rate of decline. The pro- and anti-inflammatory cytokine genotype is linked negatively and positively, respectively, with life-span, because of its influence on inflammation.
PURPOSE OF REVIEW: During ageing there may be the onset of a chronic inflammatory state. This review examines the underlying causes of this phenomenon and the role that genotype plays in its intensity. RECENT FINDINGS: There are predisposing factors for the chronic inflammation that occurs during ageing. These include increased oxidative stress, a decrease in ovarian function, a decrease in stress-induced glucocorticoid sensitivity of pro-inflammatory cytokine production in men, and an increased incidence of asymptomatic bacteriuria. Obesity induces chronic inflammation. Inflammation is a key factor in the progressive loss of lean tissue and impaired immune function observed in ageing. Polymorphisms in the promoter regions of pro- and anti-inflammatory cytokine genes influence the level of cytokine production and the ageing process. Thus, a genotype for high pro-inflammatory cytokine production results in high cytokine production and may accelerate the rate of tissue loss. Conversely, polymorphisms in the genes for anti-inflammatory cytokines may result in a slowing of tissue loss. In the healthy aged male population, the former polymorphisms are under-represented and the latter over-represented, indicating a genetically determined survival advantage in maintaining inflammation at a low level. Nutrients with anti-inflammatory properties, such as vitamin E and n-3 polyunsaturated fatty acid, may reduce the level of chronic inflammation and thereby ameliorate tissue and functional loss during ageing. New evidence suggests that, for the latter nutrient, gene-nutrient interactions occur that alter the effectiveness of dietary therapy. SUMMARY: Ageing is associated with increased levels of chronic inflammation. This plays a major role in the decline in immune function and lean body mass. Anti-inflammatory nutrient therapy may slow the rate of decline. The pro- and anti-inflammatory cytokine genotype is linked negatively and positively, respectively, with life-span, because of its influence on inflammation.
Authors: Hongqiao Zhang; Honglei Liu; Kelvin J A Davies; Constantinos Sioutas; Caleb E Finch; Todd E Morgan; Henry Jay Forman Journal: Free Radic Biol Med Date: 2012-03-06 Impact factor: 7.376
Authors: Qiang Shi; Jane F Vandeberg; Catherine Jett; Karen Rice; Michelle M Leland; Leslie Talley; Rampratap S Kushwaha; David L Rainwater; John L Vandeberg; Xing Li Wang Journal: Am J Clin Nutr Date: 2005-10 Impact factor: 7.045
Authors: Dennis T Villareal; Gordon I Smith; David R Sinacore; Krupa Shah; Bettina Mittendorfer Journal: Obesity (Silver Spring) Date: 2010-05-20 Impact factor: 5.002
Authors: Li Fan; Andrew S Levey; Vilmundur Gudnason; Gudny Eiriksdottir; Margret B Andresdottir; Hrefna Gudmundsdottir; Olafur S Indridason; Runolfur Palsson; Gary Mitchell; Lesley A Inker Journal: J Am Soc Nephrol Date: 2014-12-19 Impact factor: 10.121
Authors: Laura C D Pomatto; Mayme Cline; Nicholas Woodward; Payam Pakbin; Constantinos Sioutas; Todd E Morgan; Caleb E Finch; Henry Jay Forman; Kelvin J A Davies Journal: Free Radic Biol Med Date: 2018-04-27 Impact factor: 7.376
Authors: Jun F Tong; Xu Yan; Mei J Zhu; Stephen P Ford; Peter W Nathanielsz; Min Du Journal: Am J Physiol Endocrinol Metab Date: 2009-01-27 Impact factor: 4.310
Authors: Albert E Jergens; Ioana M Sonea; Annette M O'Connor; Linda K Kauffman; Sinisa D Grozdanic; Mark R Ackermann; Richard B Evans Journal: Comp Med Date: 2009-04 Impact factor: 0.982